A neuropathological study of cerebrovascular abnormalities in a signal transducer and activator of transcription 3–deficient patient - 06/11/15
Doi : 10.1016/j.jaci.2015.05.021
Marie-Olivia Chandesris, MD a, b, c 
, Françoise Gray, MD, PhD d, Patrick Bruneval, MD b, e, Arshid Azarine, MD b, f, Nathalie Boddaert, MD, PhD b, g, Catherine Oppenheim, MD, PhD b, h, i, François Paraire, MD j, Emmanuel Touzé, MD, PhD b, k, l, Damien Bonnet, MD, PhD b, m, Olivier Hermine, MD, PhD a, b, c, n, Olivier Lortholary, MD, PhD b, c, o, p, q, Valérie Cormier-Daire, MD, PhD b, n, r, Pierre Boutouyrie, MD, PhD b, s, t, Ziad Mallat, PhD b, t, u, Alain Fischer, MD, PhD b, c, n, v, w, Capucine Picard, MD, PhD b, c, x, y
, Françoise Gray, MD, PhD d, Patrick Bruneval, MD b, e, Arshid Azarine, MD b, f, Nathalie Boddaert, MD, PhD b, g, Catherine Oppenheim, MD, PhD b, h, i, François Paraire, MD j, Emmanuel Touzé, MD, PhD b, k, l, Damien Bonnet, MD, PhD b, m, Olivier Hermine, MD, PhD a, b, c, n, Olivier Lortholary, MD, PhD b, c, o, p, q, Valérie Cormier-Daire, MD, PhD b, n, r, Pierre Boutouyrie, MD, PhD b, s, t, Ziad Mallat, PhD b, t, u, Alain Fischer, MD, PhD b, c, n, v, w, Capucine Picard, MD, PhD b, c, x, y a Department of Haematology, Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
c Centre de référence des déficits immunitaires héréditaires (CEREDIH), Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
g Department of Paediatric Radiology, Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
m M3C Centre de Référence pour les Malformations Cardiaques Congénitales Complexes, Department of Paediatric Cardiology, Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
r Department of Genetics, Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
v Paediatric Immunohematology Unit, Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
x Study Centre for Primary Immunodeficiencies, Necker Children's Hospital, Assistance Publique–Hôpitaux de Paris (APHP), Paris, France
b Sorbonne Paris Cité, Paris Descartes University, Imagine Institute, Paris, France
d Department of Pathology (Neuropathology), Lariboisière Hospital, APHP, Paris 7 University, Paris, France
e Department of Pathology, Georges Pompidou European Hospital, APHP, Paris, France
f Department of Radiology, Georges Pompidou European Hospital, APHP, Paris, France
s Pharmacology Department, Georges Pompidou European Hospital, APHP, Paris, France
h Department of Neuroradiology, Sainte-Anne Hospital, Paris, France
i INSERM UMR 894, Paris, France
j Department of Forensic Medicine and Pathology, Raymond Poincaré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Garches, France
k Department of Neurology, Sainte-Anne Hospital, Paris, France
l University of Caen Basse-Normandie, Côte de Nacre Hospital, Caen, France
n INSERM UMR 1163, IMAGINE Institut, Paris, France
o Department of Infectious Diseases and Tropical Medicine, Necker Children's Hospital, APHP, Paris, France
p Pasteur Institute, Paris, France
q CNRS URA3012, Paris, France
t INSERM U970, Paris-Cardiovascular Research Centre (PARCC), Paris, France
u Division of Cardiovascular Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom
w College de France, Paris, France
y Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, IMAGINE Institute, Paris, France
| Disclosure of potential conflict of interest: E. Touzé is a board member for BMS, Pfizer, Boehringer Ingelheim, and Bayer and has received payment for lectures from Boehringer Ingelheim, Pfizer, Bayer, and BMS. O. Hermine is a board member for, has consultant arrangements with, and receives stock/stock options from AB Science; has received research support from Celgene and Novartis; and has received payment for lectures from Jansen and Celgene. O. Lortholary is a board member for MSD, has consultant arrangements with Gilead, and has received payment for lectures from Pfizer, Astellas, Gilead, Merck, and Schering. A. Fischer has received research support from the European Research Council (“PIDIMMUN” Grant no. 249816). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 136 - N° 5
P. 1418 - novembre 2015 Retour au numéro
Article précédent
- New wheat allergens related to baker's asthma
- Cordula Bittner, Ulrike Peters, Karsten Frenzel, Horst Müsken, Reinhold Brettschneider
- Recommendations on probiotics in allergy prevention should not be based on pooling data from different strains
- Hania Szajewska, Raanan Shamir, Dominique Turck, Johannes B. van Goudoever, Walter A. Mihatsch, Mary Fewtrell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?